6-(4-chlorophenyl)sulfonyl-7-cyclohexyl-5-methyl-2-(trifluoromethyl)-6,7-dihydropyrazolo[1,5-a]pyrimidine
C20H21ClF3N3O2S — CID 91141814
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(4-chlorophenyl)sulfonyl-7-cyclohexyl-5-methyl-2-(trifluoromethyl)-6,7-dihydropyrazolo[1,5-a]pyrimidine
6-(4-chlorophenyl)sulfonyl-7-cyclohexyl-5-methyl-2-(trifluoromethyl)-6,7-dihydropyrazolo[1,5-a]pyrimidine (PubChem CID 91141814) has the molecular formula C20H21ClF3N3O2S and a molecular weight of 459.92 g/mol. Its IUPAC name is 6-(4-chlorophenyl)sulfonyl-7-cyclohexyl-5-methyl-2-(trifluoromethyl)-6,7-dihydropyrazolo[1,5-a]pyrimidine.
Molecular Properties
| Compound Name | 6-(4-chlorophenyl)sulfonyl-7-cyclohexyl-5-methyl-2-(trifluoromethyl)-6,7-dihydropyrazolo[1,5-a]pyrimidine |
|---|---|
| PubChem CID | 91141814 |
| Molecular Formula | C20H21ClF3N3O2S |
| Molecular Weight | 459.92 g/mol |
| Exact Mass | 459.10 |
| IUPAC Name | 6-(4-chlorophenyl)sulfonyl-7-cyclohexyl-5-methyl-2-(trifluoromethyl)-6,7-dihydropyrazolo[1,5-a]pyrimidine |
| SMILES | CC1=Nc2cc(C(F)(F)F)nn2C(C2CCCCC2)C1S(=O)(=O)c1ccc(Cl)cc1 |
| InChI | InChI=1S/C20H21ClF3N3O2S/c1-12-19(30(28,29)15-9-7-14(21)8-10-15)18(13-5-3-2-4-6-13)27-17(25-12)11-16(26-27)20(22,23)24/h7-11,13,18-19H,2-6H2,1H3 |
| InChIKey | RJZYAALWACBRDF-UHFFFAOYSA-N |
| XLogP | 5.63 |
| TPSA | 64.32 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 459.92 |
| LogP ≤ 5 | 5.63 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 91141814 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.